Literature DB >> 17073840

Seasonal variation of the onset of presentations in stage 1 sarcoidosis.

S S Demirkok1, M Basaranoglu, O Akbilgic.   

Abstract

Sarcoidosis is a chronic disease with an unknown aetiology. Our aim was to evaluate the pattern of seasonality of stage 1 sarcoidosis subjects who had symptoms by all cases, by age and by both genders. In this study, we used Roger's test for cyclic variation to prove that this seasonal variation was more than chance. Four hundred ninety-two consecutive patients with sarcoidosis who presented different clinical symptoms were included in this retrospective cohort study. According to the chest X-ray examinations, 185 patients had stage 1, while 307 patients in control group had stage 0, 2, 3 and 4 sarcoidosis. The demographic features, presenting clinical features, course of the disease, initial diagnostic methods and both the month and the age at the initial diagnosis for each patient were analysed on chart reviews. Roger's test for cyclic variation was used to determine the significance of any seasonal variation of incidence. Otherwise, t-test was used. The distribution of cumulative monthly presentations for patients with stage 1 peaked in April (108% above the average) and was lowest in October, November and December (48% below the average) (p < 0.001). Seasonality of the control group peaked in May (84% above the average) and was lowest in August (69% below the average) (p < 0.001). The seasonal pattern of subjects within both groups was influenced by some age groups and by both genders (p < 0.05). Some differences in the amplitude of the seasonal variation by age and by both genders increase the possibility of interactions among age, gender and the disease. Further well-designed and prospective studies are required to better understand the importance of our findings and the pathogenesis of the disease.

Entities:  

Mesh:

Year:  2006        PMID: 17073840     DOI: 10.1111/j.1742-1241.2005.00773.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  6 in total

Review 1.  Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.

Authors:  Amy S McKee; Shaikh M Atif; Michael T Falta; Andrew P Fontenot
Journal:  J Immunol       Date:  2022-04-15       Impact factor: 5.426

2.  CD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope.

Authors:  Johan Grunewald; Andrew P Fontenot; Sarah A Greaves; Avinash Ravindran; Radleigh G Santos; Lan Chen; Michael T Falta; Yang Wang; Angela M Mitchell; Shaikh M Atif; Douglas G Mack; Alex N Tinega; Lisa A Maier; Shaodong Dai; Clemencia Pinilla
Journal:  J Exp Med       Date:  2021-08-19       Impact factor: 17.579

3.  An analysis of seasonality of sarcoidosis in the United States veteran population: 2000-2007.

Authors:  A K Gerke; F Tangh; M Yang; J E Cavanaugh; P M Polgreen
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2012-10       Impact factor: 0.670

4.  Indications for performing flexible bronchoscopy: Trends over 34 years at a tertiary care hospital.

Authors:  Ankit Amar Gupta; Inderpaul Singh Sehgal; Sahajal Dhooria; Navneet Singh; Ashutosh Nath Aggarwal; Dheeraj Gupta; Digambar Behera; Ritesh Agarwal
Journal:  Lung India       Date:  2015 May-Jun

Review 5.  Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease.

Authors:  Sarah A Greaves; Shaikh M Atif; Andrew P Fontenot
Journal:  Front Immunol       Date:  2020-03-18       Impact factor: 7.561

6.  Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study.

Authors:  Alicia K Gerke; Ming Yang; Fan Tang; Joseph E Cavanaugh; Philip M Polgreen
Journal:  BMC Pulm Med       Date:  2012-07-09       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.